期刊
JOURNAL OF CELLULAR BIOCHEMISTRY
卷 102, 期 6, 页码 1375-1388出版社
WILEY
DOI: 10.1002/jcb.21594
关键词
endoglin; transforming growth factor-beta receptors; hereditary hemorrhagic telangiectasia; vascular pathology; vascular endothelium; vascular smooth muscle
资金
- NCRR NIH HHS [P20 RR015555-049001, P20 RR015555-040004, P20 RR015555, P20 RR015555-076465, RR15555] Funding Source: Medline
- NHLBI NIH HHS [R01 HL083151, R01-HL083151, R01 HL083151-01A2] Funding Source: Medline
The broad role of the transforming growth factor beta (TGFP) signaling pathway in vascular development, homeostasis, and repair is well appreciated. Endoglin is emerging as a novel, complex, and poorly understood regulatory component of the TGFP receptor complex, whose importance is underscored by its recognition as the site of mutations causing hereditary hemorrhagic telangiectasia (HHT) [McAllister et al., 1994]. Extensive analyses of endoglin function in normal developmental mouse models [Bourdeau et al., 1999; Li et al., 1999; Arthur et al., 2000] and in HHT animal models [Bourdeau et al., 2000; Torsney et al., 20031 exemplify the importance of understanding endoglin's biochemical functions. However, novel mechanisms underlying the regulation of these pathways continue to emerge. These mechanisms include modification of TGFP receptor signaling at the ligand and receptor activation level, direct effects of endoglin on cell adhesion and migration, and emerging roles for endoglin in the determination of stem cell fate and tissue patterning. The purpose of this review is to highlight the cellular and molecular studies that underscore the central role of endoglin in vascular development and disease. J. Cell. Biochem. 102: 1375-1388, 2007. (c) 2007 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据